Document is current
Any future updates will be listed below
-
Authors
Camero, Simona
Milazzo, Luisa
Vulcano, Francesca
Ceccarelli, Federica
Pontecorvi, Paola
Pedini, Francesca
Rossetti, Alessandra
Scialis, Elena Sofia
Gerini, Giulia
Cece, Fabrizio
Pomella, Silvia
Cassandri, Matteo
Porrazzo, Antonella
Romano, Enrico
Festuccia, Claudio
Gravina, Giovanni Luca
Ceccarelli, Simona
Rota, Rossella
Lotti, Lavinia Vittoria
Midulla, Fabio
Angeloni, Antonio
Marchese, Cinzia
Marampon, Francesco
Megiorni, Francesca
-
Funding
Funding for this research was provided by:
Associazione Italiana per la Ricerca sul Cancro (IG 2020 - ID. 570)
Sapienza Università di Roma (Ateneo 2021 n. RM12117A80C860E9, Ateneo 2022 n. RM12218166DC5D61)
- License Information
-
More Information
Article History
Received: 22 January 2024
Accepted: 18 June 2024
First Online: 8 July 2024
Declarations
:
: According to the recommendations of the European Community guidelines (2010/63/UE and DL 26/2014 for the use of laboratory animals) and the Italian National Institute of Health (ISS) guidelines, complying with the Italian Government Regulation n.116 27 January 1992 for the use of laboratory animals, the in vivo study was approved by the Ethics Committee of the Italian National Institute of Health (ISS) registered office in Rome, Viale Regina Elena 299, with the code 221/2022-PR (D9997.140, 4 April 2022).
: Not applicable.
: C.F. is a scientific advisor at Evgen Pharma. The other authors declare that they have no competing interests.
